πŸ‡ΊπŸ‡Έ FDA
Patent

US 10253333

DNA-binding proteins and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 10253333 (DNA-binding proteins and uses thereof) held by Sangamo Therapeutics, Inc. expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61P, A61P25/00, A61P27/02